Not FDA-approved Bones & muscles

CJC-1295

CJC-1295 is a GHRH analog (secretagogue). It is filed in this library under bones & muscles, a navigation topic rather than a statement of where it acts. As a regulatory matter it is not approved by the FDA for any use.

Regulatory status

CJC-1295 is not approved by the FDA for any use.

It is sold outside the approved-drug system, which means no regulator has reviewed its manufacturing, its purity or its effects.

The evidence

What has actually been published

6 sources on CJC-1295 published between 1994 and 2026, each resolved to its journal of record. Titles are listed so you can judge the evidence rather than take a summary on trust.

Nearby

Other peptides acting on bones & muscles

Start with your own numbers.

Before any compound, the useful question is what your bloodwork already says. The OPTML Score reads a full panel against optimal ranges.

See the OPTML Score

Educational reference only. This page explains what has been published about CJC-1295. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.

Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.

All 150 peptides